Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron formulations for reducing capsaicin-induced inflammation
IRCT20181208041882N11Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ondansetron and capsaicin (4 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Burning intensity caused by capsaicin. Started Feb 2020; status: completed.
02
Drugs
ondansetroncapsaicin
Beyond the preview
Go deeper on IRCT20181208041882N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181208041882N11.